← Leaderboards
Kevin F Sullivan
Scripps Research Institute
$1,947,634
Attributed
$1,947,634
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,947,634 · 2
By mechanism
R01$1,920,273 · 1
M01$27,361 · 1
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute
Same institution · by research overlap
- John A Tainer$59,518,005
- Erica Ollmann Saphire$52,684,297
- Paul R Russell$17,137,122
- John Johnson$22,284,193
- Juan C. De La Torre$34,810,527
Others in their field
Top investigators on “Centromere”
- Don W. Cleveland · University Of California San Diego$19,838,120
- Gary H. Karpen · University Of California Berkeley$16,921,343
- Ben E. Black · University Of Pennsylvania$13,289,384
- Michael Lampson · University Of Pennsylvania$12,096,625
- Susan Biggins · Fred Hutchinson Cancer Research Center$10,976,990
- Kerry S Bloom · University Of North Carolina Chapel Hill$10,446,167
Research focus
CentromereLaboratory MouseChromatinChromosome MovementProtein Structure FunctionNucleosomesTissue /Cell CultureHistonesGene MutationX Ray CrystallographyElectron MicroscopyMass SpectrometryPosttranslational ModificationsCell CycleNucleoproteinsNucleic Acid SequenceCell NucleusHuman Genetic Material TagHuman DataDna Binding ProteinImmunoprecipitationLaboratory RabbitTransfectionMolecular Cloning
Grant awards (7)
Assembly and Function of Human Centromere Chromatin$409,292
R01 · FY2004 · GM
Assembly and Function of Human Centromere Chromatin$409,292
R01 · FY2003 · GM
Assembly and Function of Human Centromere Chromatin$409,292
R01 · FY2002 · GM
GENETIC STUDIES OF NUCLEAR DIVISION$0
M01 · FY2002 · RR
Assembly and Function of Human Centromere Chromatin$374,750
R01 · FY2001 · GM
TARGETING AND FUNCTION OF CENTROMERE PROTEIN A$317,647
R01 · FY2000 · GM
GENETIC STUDIES OF NUCLEAR DIVISION$27,361
M01 · FY2000 · RR